A listing of recent Commerce Department antidumping and countervailing duty messages posted on CBP's website May 3, along with the case number(s) and CBP message number, is provided below. The messages are available by searching for the listed CBP message number at CBP's ADCVD Search page.
A listing of recent Commerce Department antidumping and countervailing duty messages posted on CBP's website May 1, along with the case number(s) and CBP message number, is provided below. The messages are available by searching for the listed CBP message number at CBP's ADCVD Search page.
The Commerce Department published notices in the Federal Register April 25 on the following AD/CV duty proceedings (any notices that announce changes to AD/CV duty rates, scope, affected firms or effective dates will be detailed in another ITT article):
The Commerce Department and the International Trade Commission published the following Federal Register notices April 25 on AD/CVD proceedings:
Suspension of liquidation and countervailing duty cash deposit requirements won't take effect until further notice for Sociedad Nacional de Galapagos C.A., Naturisa S.A., Holding Sola & Sola Solacciones S.A., and Empacadora Champmar S.A., the Commerce Department said in a notice released April 24 amending its preliminary determination in its CVD investigation on frozen warmwater shrimp from Ecuador (C-331-806). The agency also is amending the all-others rate for Ecuador it set in the April 1 preliminary determination (see 2403290027).
The following are short summaries of recent CBP NY rulings issued by the agency's National Commodity Specialist Division in New York:
CBP issued the following releases on commercial trade and related matters:
Correction: Sen. Bill Cassidy, R-La., said at an April 17 Senate Finance Committee hearing on the administration's trade agenda that a whistleblower found “unsanitary conditions and rampant labor abuses” in the Indian shrimp industry, asking whether CBP would take action (see 2404170074).
Correction: Sen. Bill Cassidy, R-La., said at an April 17 Senate Finance Committee hearing on the administration's trade agenda that a whistleblower found “unsanitary conditions and rampant labor abuses” in the Indian shrimp industry, asking whether CBP would take action (see 2404170074).
On April 17, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of: